Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Danaher Corp (NY:DHR)

205.14 +2.68 (+1.32%)
Official Closing Price Updated: 7:00 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Insights into Danaher's Upcoming Earnings
 
Via Benzinga
Danaher (DHR) Reports Q2: Everything You Need To Know Ahead Of Earnings
Diversified science and technology company Danaher (NYSE:DHR) will be reporting earnings this Tuesday before market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Gapping S&P500 stocks in Monday's session
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY)
Let’s dig into the relative performance of Revvity (NYSE:RVTY) and its peers as we unravel the now-completed Q1 research tools & consumables earnings season. 
Via StockStory
Topics Economy
What Does the Market Think About Danaher?
 
Via Benzinga
How Do Investors Really Feel About Danaher?
 
Via Benzinga
$100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
P/E Ratio Insights for Danaher
 
Via Benzinga
What Analysts Are Saying About Danaher Stock
 
Via Benzinga
Meta Platforms To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
3 Low-Volatility Stocks in the Doghouse
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Here's How Much $1000 Invested In Danaher 10 Years Ago Would Be Worth Today
 
Via Benzinga
Jim Cramer 'Worried' About Workday, Calls Applied Digital 'A Good Spec'
Stay away from Workday, Jim Cramer says. "I'm worried. There's a lot of companies coming for Workday, and I don't like that." 
Via Benzinga
Expert Outlook: Danaher Through The Eyes Of 11 Analysts
 
Via Benzinga
3 of Wall Street’s Favorite Stocks Skating on Thin Ice
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Here's How Much $1000 Invested In Danaher 10 Years Ago Would Be Worth Today
 
Via Benzinga
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
From SCIEX
Via Business Wire
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
From SCIEX
Via Business Wire
SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations
From SCIEX
Via Business Wire
1 Cash-Producing Stock with Exciting Potential and 2 to Question
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
It's Unofficially Summer. Time to Get Outside, and Talk With Decking Expert Trex CEO Bryan Fairbanks
Via The Motley Fool
Topics Artificial Intelligence World Trade
8 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the major indices fell further in the afternoon (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft... 
Via StockStory
Topics Bonds Stocks
Market Whales and Their Recent Bets on DHR Options
 
Via Benzinga
Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy
From Integrated DNA Technologies
Via Business Wire
Q1 Research Tools & Consumables Earnings: Danaher (NYSE:DHR) Impresses
Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its peers. 
Via StockStory
Topics Economy
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
1 S&P 500 Stock with Competitive Advantages and 2 to Keep Off Your Radar
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
Revvity (RVTY) Q1 Earnings Report Preview: What To Look For
Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Market Whales and Their Recent Bets on DHR Options
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.